Medications Updated During July 2019, From Oldest to Newest

Page 1 of 35 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Zebutal (Butalbital, Acetaminophen and Caffeine)

Zebutal (butalbital, acetaminophen and caffeine capsules) USP 50 mg/325 mg/40 mg is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence…

Mayne Pharma Inc.1 July 2019

Cefuroxime Axetil

Cefuroxime axetil tablets are a cephalosporin antibacterial drug indicated for the treatment of the following infections due to susceptible bacteria: (1) Pharyngitis/tonsillitis (adults…

Lupin Pharmaceuticals, Inc.1 July 2019

Gabapentin

Postherpetic Neuralgia. Gabapentin Capsules is indicated for the management of postherpetic neuralgia in adults. Epilepsy. Gabapentin Capsules USP is indicated as adjunctive therapy in…

Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC1 July 2019

Tropicamide

For mydriasis and cycloplegia for diagnostic procedures. CONTRAINDICATIONS: Contraindicated in persons showing hypersensitivity to any component of this preparation. WARNINGS. FOR TOPICAL…

Bausch & Lomb Incorporated1 July 2019

NITROLINGUAL (Nitroglycerin)

Nitrolingual Pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. Nitrolingual Pumpspray is a nitrate vasodilator…

Allegis Pharmaceuticals, LLC1 July 2019

Page 1 of 35 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.